| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| Q5121 |
Injection, infliximab-axxq, biosimilar, (avsola), 10 mg |
237 |
120 |
$314K |
| 99601 |
|
2,959 |
1,791 |
$200K |
| J3032 |
Injection, eptinezumab-jjmr, 1 mg |
49 |
45 |
$110K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,310 |
868 |
$59K |
| 99602 |
Nursing care in home rn |
667 |
457 |
$26K |
| 96415 |
|
336 |
214 |
$4K |
| S9379 |
Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
204 |
135 |
$4K |
| 96401 |
|
43 |
27 |
$907.56 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
147 |
102 |
$801.60 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
78 |
40 |
$620.14 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
42 |
27 |
$230.94 |
| 36415 |
Collection of venous blood by venipuncture |
74 |
42 |
$69.22 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
68 |
52 |
$36.97 |